HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BSE interim final rule

This article was originally published in The Rose Sheet

Executive Summary

Cosmetic, Toiletry and Fragrance Association requests FDA further clarify that all tallow derivatives are exempt from the interim final rule governing use of cattle-derived ingredients in food and cosmetics in comments submitted to the agency Oct. 12. Rule states that FDA believes tallow has a "negligible risk of transmitting BSE," a position with which CTFA concurs. However, manufacturers must document that tallow does not contain prohibited materials and no more than .15% insoluble impurities (1"The Rose Sheet" July 12, 2004, p. 10). CTFA also asks FDA to clarify milk and its byproducts are not included as prohibited cattle materials, noting the prohibition of milk for use in cosmetics is believed to be an "unintended result" of the regulation...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012523

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel